文献速递血液透析通路

不同导管导向经皮血栓清除术后动静脉透析通路通畅率的比较

Comparing Patency Rates of Arteriovenous Dialysis Access following Percutaneous Thrombectomy Using Various Catheter Directed Therapies.
PubMed 文献 · Ann Vasc Surg · 2023-01-07

对2016至2020年236例血栓性血液透析通路患者的413次经皮血栓清除术进行回顾性分析,比较Angiojet、Trerotola和Penumbra三种装置的一期及累积功能通畅率。Penumbra的一期和累积功能通畅率均低于Angiojet和Trerotola,差异有统计学意义(P < 0.05)。

要点

  • Penumbra组的一期通畅率和累积功能通畅率均显著低于Angiojet组和Trerotola组(P < 0.05)。
  • Angiojet和Trerotola两种方法的一期及累积功能通畅率优于Penumbra。
  • 不同经皮血栓清除方法获得的通畅率并不相同。

核心结论

  • 不同经皮血栓清除方法的一期通畅率和累积功能通畅率并不相同,Angiojet和Trerotola优于Penumbra。

研究设计与样本

  • 回顾性分析2016至2020年236例血栓性血液透析通路患者,共413次经皮血栓清除术,比较Angiojet、Trerotola和Penumbra三种装置。

主要发现

  • 共完成413次经皮血栓清除术,其中Angiojet 98次、Trerotola 103次、Penumbra 212次。
  • 平均一期通畅时间(天):Angiojet 194、Trerotola 204、Penumbra 107。
  • 平均累积功能通畅时间(天):Angiojet 450、Trerotola 475、Penumbra 292。
  • Angiojet vs Penumbra及Trerotola vs Penumbra均显示Penumbra导管通畅率降低,差异有统计学意义(P < 0.05)。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Arteriovenous fistulas often require frequent interventions to maintain patency for hemodialysis. Interventions may include open or percutaneous thrombectomy with additional targeted interventions as indicated. We evaluated the primary and cumulative functional patency rates following three unique approaches to percutaneous thrombectomy of thrombosed dialysis access. METHODS: A retrospective review of 236 unique patients who presented with thrombosed hemodialysis access was analyzed over a period of 4 years from 2016 to 2020. We analyzed a total of 413 procedures that utilized 3 separate percutaneous thrombectomy devices to assist with restoring patency. The Indigo System CAT-D Aspiration Thrombectomy Catheter (Penumbra; Alameda, CA), the Arrow-Trerotola Rotational Thrombectomy System (Teleflex; Wayne, PA) and the Angiojet Rheolytic Thrombectomy Catheter (Boston Scientific, Marlborough, MA) devices were compared for primary and cumulative functional patency. Primary patency was defined as time from percutaneous thrombectomy to next intervention (Angioplasty, stenting, and repeat thrombectomy). Cumulative functional patency was defined as time from percutaneous thrombectomy to time of access abandonment. Medical record chart review was utilized to determine patency rates. RESULTS: A total of 413 percutaneous thrombectomy procedures were performed. Of the procedures performed, 98 utilized Angiojet, 103 utilized Trerotola, and 212 used Penumbra. The mean primary patency rates in (days) for the devices were as follows: Angiojet (194), Trerotola (204), and Penumbra (107). The mean cumulative functional patency rates (in days) for the devices were as follows: rheolytic thrombectomy (450 days), aspiration thrombectomy (292 days), and rotational thrombectomy (475 days). Angiojet versus Penumbra and Trerotola versus Penumbra both showed diminished patency rates when using the Penumbra catheter that were statistically significant (P < 0.05). CONCLUSIONS: All percutaneous thrombectomy approaches do not result in the same primary or cumulative functional patency rates. Approaches with Trerotola and Angiojet resulted in improved primary and cumulative functional patency rates compared to those using Penumbra.

来源:Ann Vasc Surg,查看原文。版权归原作者所有。

引用

  1. Hicks A, Grzeda A, Schucht J, et al. Comparing Patency Rates of Arteriovenous Dialysis Access following Percutaneous Thrombectomy Using Various Catheter Directed Therapies. Ann Vasc Surg. 2023. PMID: 36623720. doi:10.1016/j.avsg.2022.12.067

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。